Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Benzer Materyaller

• FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
  Yazar:: Griffiths, G, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Issues in data monitoring and interim analysis of trials.
  Yazar:: Grant, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• CANparent trial evaluation: second interim report
  Yazar:: Cullen, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• CANparent trial evaluation: First interim report
  Yazar:: Cullen, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial
  Yazar:: Masahide Oki, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-12-01)